Hemolysis in patients with post aortic stenosis treatment evaluated by erythrocyte creatine -Comparison of surgical aortic valve replacement and transcatheter aortic valve implantation-

Hemolysis in patients with post aortic stenosis treatment evaluated by erythrocyte creatine -Comparison of surgical aortic valve replacement and transcatheter aortic valve implantation- - Difference of hemolysis in patients with surgical and transcatheter aortic stenosis treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036427

Enrollment

Registered

2019-05-07

Start date

2019-05-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic stenosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Scheduled surgical aortic valve replacement or transcatheter aortic valve implantation in patients with severe aortic stenosis

Exclusion criteria

Exclusion criteria: Already received surgical treatment for either cardiac valve disease Required transfusion preoperative period Patients with autoimmune hemolytic anemia Patients with malignant tumor Patients who received regular dialysis

Design outcomes

Primary

Measure	Time frame
Comparison of hemolysis in patients with surgical aortic valve replacement and transcatheter aortic valve implantation	—

Secondary

Measure	Time frame
Comparison between pre and post treatment in patients with surgical aortic valve replacement or transcatheter aortic valve implantation Long-term cardiovascular outcome and hemolysis	—

Countries

Japan

Contacts

Public ContactShinobu Bandou

Kansai Medical University Medical Center Department of Cardiology

bandoshi@takii.kmu.ac.jp+81-6-6992-1001

Outcome results